Monsanto (MON) Signs Deal with ToolGen for CRISPR Technology – Zacks.com
Zacks.com |
Monsanto (MON) Signs Deal with ToolGen for CRISPR Technology
Zacks.com ToolGen is a biotechnology company primarily focused on developing non-imitable genome editing technologies like CRISPR. Cultivators seek diverse seed choices for maximizing their crop yield and minimizing resource utilization. Hence, agricultural … Monsanto gains access to ToolGen CRISPR platform |
